Catelani Michael 4
4 · Anixa Biosciences Inc · Filed Jun 2, 2021
Insider Transaction Report
Form 4
Catelani Michael
President, COO & CFO
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-06-01+100,000→ 100,000 totalExercise: $4.02Exp: 2031-06-01→ Common Stock (100,000 underlying) - Award
Employee Stock Option (Right to Buy)
2021-06-01+100,000→ 100,000 totalExercise: $4.02Exp: 2031-06-01→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
- [F2]The options vest and become exercisable as follows: (i) 25,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $5.00, (ii) 25,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $6.00, (iii) 25,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $7.00, and (iv) 25,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $8.00.
- [F3]The options vest and become exercisable in thirty-six (36) equal monthly installments beginning June 30, 2021.